Good Afternoon and welcome to HotCopper Highlights for Week 29 of the year, I’m Jon Davidson. This segment wrapping up what you were watching and discussing the most on the forums this week, let’s get into it with the most viewed.
Lumos Diagnostics copped a lot of attention midweek after it revealed it’s on the cusp of a $400 million dollar deal with a distributor in the US. It’s designed a fingerprick blood test that can diagnose bacterial infections, kind of like a watered down but legitimate version of what the infamous company Theranos claimed to have produced. The only thing is, that big contract for Lumos is reliant on the FDA issuing a key waiver.
Elsewhere, Trigg Minerals early week generating a lot of attention on the forums after the ASX slapped the company on the wrist for basing estimates around a recently acquired antimony project on a non-compliant report without a methodology section. Trigg this week re-issued an exploration target for the project under the JORC rules which investors have largely liked.
Finally, always-hot healthcare smallcap Imugene pulled in interested eyes a few times this week: first, the company reported two complete responses in ongoing trials of its Azer-cel product, but then tow days later, the company dropped a capital raise, snagging $22.5 million in a placement.
So what about the most discussed?
This mightn’t be a surprise – Droneshield one of the hottest discussed this week. The ever sensational defence stock soared above $4 a share this week, before pulling back on Thursday and hitting around $3.30 in Friday morning trades. It’s been about a year to date since the company’s stock price last tanked after hitting just over $2.50 a share; while it’s undertaking an expansion, market cap and revenue remain quite far apart.
Pilbara Minerals meanwhile generated chatter throughout the week after a small recovery in a major lithium benchmark, at least on a week on week basis, leading some to question if we’re about to see a revival in the price of the EV metal. That probably isn’t the case, especially if one zooms out to look at the five year price chart. This week’s 6% gain was, sadly, pretty negligible on the grand scale.
Finally, rare earths junior Ionic Rare Earths the topic of many posts across the forums in Week 29 after the US government last week bought a stake in an American rare earths thematic, leaving many to wonder if the same might happen down under. That bit of news has been enough to generate excitement outweighing the fact neodymium prices remain fairly unexciting.
That’s HotCopper Highlights for this week, I’m Jon Davidson, have a great weekend and we’ll see you on Monday.
Join the discussion: See what’s trending right now on HotCopper, Australia’s largest stock forum, and be part of the conversations that move the markets.